Your cart is empty
GHRH(1-29) Analogue
Sermorelin is a synthetic peptide corresponding to the first 29 amino acids of growth-hormone-releasing hormone, studied in research on the GH/IGF-1 axis.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Sermorelin is a synthetic peptide corresponding to the first 29 amino acids of growth-hormone-releasing hormone, studied in research on the GH/IGF-1 axis.
Experimental models examine GHRH-receptor stimulation and downstream secretory dynamics under controlled conditions.
Sermorelin (GHRH 1-29) is the shortest fully active fragment of growth-hormone-releasing hormone, characterized in research for its ability to stimulate physiologic growth-hormone release. Investigations have examined GHRH-receptor pharmacology and GH-secretory dynamics.
Studies span endocrine-axis and neuroendocrine research frameworks under structured conditions.
Sermorelin was developed from the characterization of growth-hormone-releasing hormone and the identification of its minimal active sequence.
Research has since used it as a reference GHRH analogue in studies of the GH/IGF-1 axis.
Research into sermorelin focuses on GHRH-receptor signaling and GH/IGF-1 axis regulation. Frameworks evaluate secretagogue pharmacology and secretory dynamics under controlled conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains the labeled quantity of sermorelin. Independent third-party analysis verifies purity, identity, and net content per batch.
The unit contains only the research compound. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
Related

Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$70.00

Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$50.00

Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$60.00

GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$90.00